ADAMTS9 and neoplasm: ADAMTS9-AS1 overexpression represses prostate cancer cell proliferation, and low expression levels of ADAMTS9-AS1 predict poorer survival than higher ADAMTS9-AS1 expression levels, suggesting that ADAMTS9-AS1 functions as a tumor suppressor in prostate cancer15.